ARL2BP and nasopharyngeal carcinoma: To test this hypothesis, we modulated the expression of BART1 in both EBV-negative and EBV-positive NPC cells and revealed that BART1 significantly propels the migration and invasion of NPC cells in vitro and the tumour metastasis in vivo animal models.